All covid-19 articles
-
News
NIH sparks concern by singling out mRNA vaccine research for added scrutiny
The Department of Health and Human Services denies mRNA research faces defunding but scientists are still worried
-
Opinion
Classifications, racial discrimination and Covid-19
Lessons with philosophical significance for how we group people and objects
-
Opinion
Chemists amid coronavirus five years on
Rebecca Trager catches up with four chemists to see how their working lives have changed since the start of the Covid-19 pandemic
-
Opinion
Chemists amid coronavirus five years on: Krystle McLaughlin
An assistant chemistry professor at a small college in New York gets her career back on track, thanks to a tenure clock extension and teaching release
-
Opinion
Chemists amid coronavirus five years on: Anya Gryn’ova
A computational chemist has moved from being group leader at a German research institute to an associate computational chemistry prof in the UK
-
Opinion
Chemists amid coronavirus five years on: Liang Zhang
Lockdown gave a young chemistry professor in China the space and time to consider the most worthwhile projects, and that has benefited his team
-
Opinion
Chemists amid coronavirus five years on: Lee Cronin
A University of Glasgow chemist describes how Covid-19 helped establish the principle of chemputation and spur a chemistry revolution
-
Opinion
Forming bonds through Covid-19
How studying chemistry helped ward off loneliness during the pandemic
-
Business
Moderna’s mRNA vaccine approved for RSV
US approval adds complementary option to protein-based vaccines for respiratory syncytial virus
-
News
EcoHealth Alliance fights back against US government funding suspension
New York-based non-profit will file documents refuting allegations about inadequate oversight of NIH-funded research in China just before the pandemic
-
Research
Elevated carbon dioxide lets Sars-CoV-2 live far longer in droplets
Study explains why good ventilation lowers transmission of Covid-19
-
News
Chinese scientist who published Sars-CoV-2 genome without approval regains access to lab
Following Zhang Yongzhen and his team’s eviction from their lab, a protest appears to have forced a U-turn from authorities
-
Business
New Covid-19 antiviral cuts symptoms by 1.5 days
Simnotrelvir already has emergency approval in China
-
-
Business
Pharmaceuticals roundup 2023
Regulatory and pricing reforms have topped industry agendas in 2023, while weight loss drugs surged and Covid-19 therapies waned
-
Feature
Battling long Covid with drugs
The challenge of finding drugs for a poorly understood disease with many symptoms is clear. Clare Sansom looks at the work going on to help the people suffering in its shadow
-
Research
ACE2 receptor not essential for Sars-CoV-2 infection, study shows
Fresh understanding linked to evolutionary plasticity of Covid-19 virus
-
News
mRNA vaccine pioneers win medicine Nobel prize
Katalin Karikó and Drew Weissman honoured for breakthroughs that enable the rapid development of new vaccines, including several of those used against Covid-19
-
Research
Air monitor detects airborne virus particles in real time
Device that detects Sars-CoV-2 could be adapted to monitor other respiratory pathogens
-
Research
AI can suggest Covid-19 antivirals from protein sequence alone
IBM model can also find molecules that bind at different sites on target proteins